Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials

Clinical trial NCT06489015 · COMPLETED

Trial details

NCT number: NCT06489015
Sponsor: Protgen Ltd
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease (AD)

Start date: 2024-08-27
Primary completion: 2026-04-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.